Why JansBrief exists
Jan Stenbeck was the smartest person I ever met. Not smart in the way academics are smart. Smart in the way that changes the world. He saw what nobody else saw. He understood that mobile telephony would revolutionise countries that hadn't even laid copper wire yet. He broke state socialist monopolies when everyone said it was impossible. He built empires out of ideas.
Every day Jan received a binder. Two people read all the world's important newspapers and magazines for him and pulled out what mattered. The things others missed. The faint signals that foreshadow great change.
I worked with Jan. I learned from him. And I have never forgotten that binder. JansBrief is my tribute to him, a modern version: global, AI-driven, available to everyone with ambition.
In memory of Jan Stenbeck
1942 — 2002
Jan Stenbeck
Tele2, Millicom, MTG, Metro
In today's edition · 12 August 2026
A patient with a severe, antibiotic-resistant E. coli infection has been successfully treated using bacteriophages — bacteria-killing viruses — engineered with CRISPR gene-editing tools. The case, reported in New Scientist this week, marks one of the clearest demonstrations yet that "phage therapy," a century-old idea long dismissed by Western medicine, can be turbocharged by modern genetic engineering to tackle infections that no available antibiotic can touch.
The logic is elegant. Phages are viruses that evolved over billions of years to hunt and destroy specific bacteria. They are ubiquitous — found in soil, sewage, oceans — and exquisitely targeted: a phage designed for E. coli will ignore everything else in the body. The problem has always been reliability. Natural phages sometimes fail because bacteria evolve resistance. By arming phages with CRISPR — essentially giving them a programmable pair of molecular scissors that shreds the bacterium's DNA — researchers have created a weapon the target cannot easily outrun.
This matters because antibiotic resistance is no longer a future threat. It is a present catastrophe. The WHO estimates that drug-resistant infections kill more than 1.2 million people a year, a number projected to rise sharply. The last entirely new class of antibiotic was discovered in 2018, and the pipeline is thin because the economics of antibiotic development are brutal: drugs taken for days, not years, generate low returns. Pharmaceutical giants have largely walked away.
CRISPR-armed phages invert those economics. Because phages are natural, infinitely diverse, and relatively cheap to engineer, they offer a platform — not a single product — that can be customised for each infection. Several biotech firms, including Locus Biosciences in the US and Phaxiam in France, are already running clinical trials. The Belgian military hospital in Brussels has treated hundreds of patients under compassionate-use rules. Georgia's Eliava Institute in Tbilisi, one of the last places where phage therapy survived during the antibiotic era, has become a pilgrimage site for patients with untreatable infections.
The regulatory challenge is significant. Phage cocktails are personalised — each patient may need a different combination — and regulators built for standardised pills struggle with bespoke biological agents. The FDA has granted individual compassionate-use approvals but has not yet created a formal pathway. The EU is further behind. This case could accelerate that process.
What makes the moment distinctive is the convergence: CRISPR precision, phage biology, and desperate clinical need colliding at a time when gene-editing costs have plummeted and sequencing a bacterium's genome takes hours, not weeks. The signal here is not just medical. It is industrial. The age of the programmable biological weapon — aimed at microbes, not people — may have begun.
Source: New Scientist · 12 August 2026
Now — Personalised infection treatment enters a new phase: The successful CRISPR-phage case is not the first use of engineered phages, but it lands at a moment when antibiotic pipelines are drying up and regulators face mounting pressure. The US FDA granted a record number of compassionate-use phage authorisations in 2025. If CRISPR-armed versions prove consistently effective, the pressure to create formal approval pathways becomes irresistible.
Soon — Phage therapy reshapes the economics of antimicrobial resistance: The global antimicrobial resistance crisis has long been framed as a market failure — antibiotics do not make enough money to justify R&D investment. Phage platforms change the calculus. Because they can be customised quickly and manufactured biologically rather than chemically, they could attract a different class of investor: those familiar with software-style platform economics rather than blockbuster drug models. Expect VC funding for phage-focused biotechs to spike within 18 months.
Later — Biology-as-platform forces a reckoning with dual-use oversight: The deeper implication is governance. A technology that can be engineered to target any bacterium — and potentially, with modifications, any cell — demands oversight frameworks that do not yet exist. The same CRISPR-phage tools that cure infections could, in theory, be reprogrammed for harm. Countries that build robust but flexible biosecurity frameworks first will attract clinical innovation; countries that wait will export their sickest patients. The phage revolution is also a biosecurity test, and the winners will be those who treat biology as a platform requiring new rules, not old analogies. Source: New Scientist · 12 August 2026; WHO AMR reports ---
China has authorised Deutsche Bank as the first non-Chinese lender permitted to settle yuan transactions in Europe, a quiet but structurally significant step in Beijing's long campaign to internationalise its currency. Until now, all European yuan clearing ran through Chinese state-owned banks. By granting the role to a Western institution, Beijing gains credibility with European corporates wary of routing payments through Chinese entities, while Deutsche Bank secures a fee-generating monopoly that could last years before competitors are admitted. The move lands at a moment when Western sanctions on Russia have made many emerging-market governments eager for dollar alternatives — and when Beijing's own capital controls still limit the yuan's appeal. The contradiction is deliberate: China wants the yuan used more widely abroad while keeping tight control of capital flows at home. Deutsche Bank's new role does not resolve that tension, but it does give Beijing a more trusted intermediary through which to manage it. Source: Bloomberg · 12 August 2026
AstraZeneca's attempt to merge with American rival Bristol Myers Squibb — which would have created the world's largest pharmaceutical company by market capitalisation — has collapsed after investors in both firms rejected the terms. The deal's failure marks the end of a brief revival of big pharma megamergers and underscores how shareholder scepticism about integration risk and pipeline overlap has shifted the balance of power from boardrooms to institutional investors. The pharmaceutical industry's consolidation logic remains intact, but the capital markets are no longer willing to write blank cheques for it. Source: Financial Times · 12 August 2026
US forces disabled the Panama-flagged container ship *Vela Nova* in the Gulf of Oman after it ignored warnings and attempted to reach an Iranian port in violation of Washington's naval blockade. A Navy helicopter fired Hellfire missiles into the engine room after the civilian crew failed to comply. The incident marks a significant escalation in enforcement of sanctions-related shipping restrictions and raises questions about proportionality and insurance risk for neutral-flag vessels transiting the region. Source: Mercopress · 12 August 2026
US venture capital firm Accel has closed a new $550 million fund focused on India in a matter of weeks, oversubscribed despite raising $650 million for its previous India fund just 19 months ago — more than half of which remains undeployed. The speed signals that global institutional investors see India's startup ecosystem as one of the few growth stories worth chasing in a cooling venture market. It also highlights the paradox of Indian tech: awash in capital commitments, yet still struggling to produce exits at the scale that would justify them. Source: TechCrunch · 12 August 2026
South Korea's 30-year government bond yield has climbed to an all-time high, driven by elevated energy prices flowing from the Hormuz crisis and weakening demand from life insurers — traditionally the largest buyers of long-dated Korean debt. The move exposes how a war in the Middle East transmits financial stress to an East Asian economy with no direct involvement in the conflict. For Seoul, the bond market signal is uncomfortable: it suggests investors see persistent inflation and rising fiscal risk, not a temporary disruption. Source: Bloomberg · 12 August 2026
Under pressure from the far right, the Merz government is allowing Taliban officials to staff Afghan diplomatic missions in Germany in exchange for smoother deportation arrangements. Afghan activists and dissidents in Germany say the arrangement puts them directly at risk, effectively giving the Taliban access to information about its opponents on European soil. Source: Politico Europe · 12 August 2026
Kenya, Botswana and Ghana are all establishing or expanding sovereign wealth funds, part of a continent-wide trend that saw 2025 become a record year for African SWFs. The push reflects a growing desire among resource-rich African states to capture more domestic value from commodity exports rather than watching proceeds flow offshore. Whether these funds will achieve genuine independence from political interference remains the critical question. Source: The Africa Report · 12 August 2026
Wealthier residents of South Africa's commercial capital are drilling private boreholes to bypass the failing municipal water system, starving the city of the revenue it needs to repair infrastructure. The vicious cycle — service collapse, private exit, deeper revenue loss — mirrors patterns seen in electricity and security across South African cities and represents a slow-motion fragmentation of the social contract. Source: The Japan Times · 12 August 2026 ---
Somewhere between Lagos, São Paulo and Bangalore, a venture capitalist running a $75 million AI-focused fund has turned the venture model inside out. Instead of relying on warm introductions, pitch decks and pattern-matching from Stanford alumni networks, he spends hundreds of millions of AI tokens a day — reading research papers, testing frontier models, scanning patent filings and parsing local-language tech blogs — to find founders that traditional Silicon Valley investors would never encounter.
The approach, reported by Rest of World, is not a stunt. It is a structural bet against the most entrenched monopoly in capitalism: access to capital. For decades, the global venture industry has operated as an insider's club. Over 75 per cent of VC dollars flow to companies within a short drive of Sand Hill Road or Shoreditch. Founders in Nairobi or Medellín with identical ideas and superior local knowledge get nothing — not because their ideas are worse, but because nobody in the room has ever heard of them.
This investor has decided that AI itself can break that bottleneck. By systematically ingesting the world's technical output in real time — not just English-language publications but Chinese, Portuguese, Hindi and Arabic research — he builds a map of emerging capability that no human network can replicate. When he finds a team working on something promising in a place the industry ignores, he moves fast, with small cheques and minimal bureaucracy.
The irony is rich. AI, the technology that Big Tech insists only it can build, is being used by an outsider to undermine the funding structures that keep Big Tech dominant. The method does not guarantee success. Most of his bets will fail, as most venture bets do. But the asymmetry is powerful: when everyone else is looking in the same direction, the person looking everywhere else only needs to be right once.
It is the oldest play in the book — use the new technology to go around the gatekeepers — executed with a tool the gatekeepers built but failed to imagine anyone else could wield.
Source: Rest of World · 12 August 2026
The Blaquier family of Argentina is consigning a collection of Impressionist and Post-Impressionist masterpieces — including works by Van Gogh, Cézanne and Degas — to Sotheby's in what may be the most significant single-owner art sale in years. The collection, assembled over generations by one of Argentina's most prominent industrial dynasties, is a reminder that Latin America's great private collections remain largely invisible to the global art market until the moment they surface. Expect fierce bidding from Gulf and Asian buyers. Source: Artnet News · 12 August 2026
An Aeon documentary revisits the Khosheutovsky khurul, a Buddhist temple built in Russia's Kalmyk region in the early 19th century to honour the Kalmyk regiment that fought Napoleon. It is the oldest Buddhist temple in Europe — an architectural anomaly that survives as evidence of the strange, circuitous routes by which faith, war and empire reshape geography. The Kalmyks, a Mongolic people deported en masse by Stalin, have spent decades rebuilding their cultural infrastructure. The temple is their anchor. Source: Aeon · 12 August 2026
Beers and Sid Motion, two independent London galleries with a combined 24 years in business, have announced they will cease operations. Their closures join a growing list of mid-tier gallery casualties in a market squeezed from above by mega-galleries with global footprints and from below by rising rents and shrinking collector confidence. The mid-tier gallery — large enough to take risks on emerging artists but too small to command auction-house attention — is becoming an endangered species. The art world talks constantly about diversity and access; the market is consolidating in the opposite direction. Source: Artnet News · 12 August 2026
A chef who made her name on South Korea's hit television competition *Culinary Class Wars* has opened a restaurant in New York that is already drawing lines. The show, which has become a cultural phenomenon in Korea, functions as a meritocratic launchpad — chefs compete on skill, not connections — and its alumni are now seeding kitchens from Seoul to Brooklyn. The Korean culinary diaspora is entering a new phase, driven by television rather than immigration patterns. Source: Eater · 12 August 2026
A newly translated book reveals how three Jewish musicians who fled Nazi persecution in the 1930s effectively created Iceland's classical music tradition from scratch. Arriving in a country with closed borders and simmering antisemitism, they founded orchestras, taught generations of students, and transformed Reykjavík's cultural landscape. The story is a potent reminder that refugees do not just survive — they build. Source: The Times of Israel · 12 August 2026
Writing in Dezeen, designer Thom Fougere argues that Canada chronically undervalues its own design culture — celebrating its actors only after Hollywood, its musicians only after Grammy success. The occasion is the government's plan to restore 24 Sussex Drive, the prime minister's residence, which Fougere sees as a missed opportunity to showcase Canadian architecture and craft at the highest level. The essay resonates beyond Canada: many mid-sized nations struggle to take their own creative output seriously. Source: Dezeen · 12 August 2026 ---
MIT Technology Review has published a deep investigation into how the term "censorship-industrial complex" — coined to describe government-adjacent efforts to monitor disinformation — has been weaponised to dismantle legitimate counter-disinformation programmes. The piece documents the shuttering of a small State Department office that tracked foreign information operations by Russia, Iran and China. The office was closed not because it failed, but because the political label attached to its work made it toxic. The consequence: the US government has fewer tools to detect foreign influence campaigns at precisely the moment those campaigns are becoming more sophisticated. The lesson is not that all content moderation is censorship, or that all government monitoring is benign — it is that collapsing complex policy questions into bumper-sticker slogans produces policy outcomes that serve neither free speech nor national security. Source: MIT Technology Review · 12 August 2026
A Dutch professor has upended his career to research iron powder as a combustion fuel — burn it, capture the rust, reduce it back to iron, repeat. The cycle produces intense heat with no greenhouse gas emissions. NRC Handelsblad reports that the technology, once dismissed as a laboratory curiosity, is now attracting industrial interest for applications where electrification is impractical: high-temperature processes in steel, cement and glass manufacturing. The energy density of iron powder exceeds that of hydrogen, it is safe to transport and store, and the Netherlands already has pilot plants running. The catch is efficiency — the reduction step requires clean energy — but as renewable electricity costs fall, the economics improve. If iron combustion scales, it fills a gap that batteries and hydrogen cannot: dispatchable, storable, high-temperature industrial heat without carbon. Source: NRC Handelsblad · 12 August 2026 ---
20
$20 million
That is how much US Immigration and Customs Enforcement plans to spend on electrified gloves — officially called the G.L.O.V.E. (Generated Low Output Voltage Emitter) — capable of delivering painful electric shocks to individuals who resist compliance. Manufactured by Compliant Technologies LLC of Lexington, Kentucky, the devices have been used in US correctional facilities but would be new to immigration enforcement. The procurement notice, published by the Department of Homeland Security, calls for thousands of units by March 2027. Whatever one's position on immigration enforcement, the normalisation of pain-compliance technology in civilian policing contexts deserves attention — not because the device is necessarily more harmful than a Taser, but because the institutional choice to equip every officer's hands with shock capability crosses a line from tool to transformation. When the instrument of control is literally worn on the body, the distance between officer and force disappears.
Source: Korea Times · 12 August 2026
In perspective
That is how much US Immigration and Customs Enforcement plans to spend on electrified gloves — officially called the G.L.O.V.E. (Generated Low Output Voltage Emitter) — capable of delivering painful electric shocks to individuals who resist compliance....
8 — Today's Wisdom
Three Jewish musicians fled Nazism in the 1930s and ended up in Iceland, a country with closed borders and widespread antisemitism. They had nothing. No network, no invitation, no plan. What they did have was knowledge, stubbornness, and a refusal to merely survive. So they built. They started orchestras, trained generations of students, and essentially created Iceland's classical music scene from scratch.
That story should be required reading for anyone taking part in the migration debate, regardless of which side they're on. Not because it proves that all immigration is good, or that all refugees are geniuses. It doesn't. But it serves as a reminder of something that both the hard right and the sentimental left often miss: that people who are forced to start over from zero sometimes build things that no native had even imagined. Not in spite of being outsiders, but precisely because of it.
This is the deepest logic of entrepreneurship. The person who has nothing to lose, who isn't embedded in the assumptions of the existing system, sees opportunities that everyone else misses. Iceland's music scene exists today because three people refused to be reduced to their refugee status. They insisted on being what they actually were: musicians, teachers, builders.
The best argument for openness has never been compassion. It has always been self-interest.
Johan Staël von Holstein
Serial entrepreneur · wakopa.ai